Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy.
Jain
R K
RK
Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School Boston, Massachusetts, USA. jain@steele.mgh.harvard.edu
D001808:Blood Vessels / Q000187:drug effects / Q000473:pathology; D002986:Clinical Trials as Topic; D006801:Humans; D009369:Neoplasms / Q000098:blood supply* / Q000628:therapy*; D009389:Neovascularization, Pathologic / Q000188:drug therapy*